Differential effects of a soluble or immobilized VEGFR-binding peptide

Integrative Biology (United Kingdom)

Volumn 4, Issue 8, 2012, Pages 914-924

  Koepsel, Justin T ^a   Nguyen, Eric H ^a   Murphy, William L ^b  

^a University of Wisconsin Madison   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; FIBRONECTIN; GLYCINEARGININEGLYCINEASPARTATESERINEPROLINE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR BINDING PEPTIDE;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL MOTILITY; CELL PROLIFERATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84864191939     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c2ib20055d     Document Type: Article

References (44)

1. M. J. Cross et al., VEGF-receptor signal transduction Trends Biochem. Sci. 2003 28 9 488 94
2. N. Ferrara H. P. Gerber J. LeCouter The biology of VEGF and its receptors Nat. Med. 2003 9 6 669 76
3. J. Folkman Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug Discovery 2007 6 4 273 86
4. L. D. D'Andrea et al., Peptide-based molecules in angiogenesis Chem. Biol. Drug Des. 2006 67 2 115 26
5. S. Soker et al., Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165 J. Biol. Chem. 1997 272 50 31582 8
6. G. Fuh et al., Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor J. Biol. Chem. 1998 273 18 11197 204
7. T. P. Boesen et al., Single-chain vascular endothelial growth factor variant with antagonist activity J. Biol. Chem. 2002 277 43 40335 41
8. G. Siemeister et al., An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells Proc. Natl. Acad. Sci. U. S. A. 1998 95 8 4625 9
9. L. D. D'Andrea et al., Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide Proc. Natl. Acad. Sci. U. S. A. 2005 102 40 14215 20
10. G. Santulli et al., In vivo properties of the proangiogenic peptide QK J. Transl. Med. 2009 7 41
11. D. Diana et al., Structural determinants of the unusual helix stability of a de novo engineered vascular endothelial growth factor (VEGF) mimicking peptide Chem.-Eur. J. 2008 14 14 4164 6
12. J. S. Lee A. J. Wagoner Johnson W. L. Murphy A modular, hydroxyapatite-binding version of vascular endothelial growth factor Adv. Mater. 2010 22 48 5494 8
13. T. R. Chan P. J. Stahl S. M. Yu Matrix-Bound VEGF Mimetic Peptides: Design and Endothelial-Cell Activation in Collagen Scaffolds Adv. Funct. Mater. 2011 21 22 4252 4262
14. J. E. Leslie-Barbick et al., The promotion of microvasculature formation in poly(ethylene glycol) diacrylate hydrogels by an immobilized VEGF-mimetic peptide Biomaterials 2011 32 25 5782 5789
15. K. L. Prime G. M. Whitesides Adsorption of Proteins onto Surfaces Containing End-Attached Oligo(Ethylene Oxide) - a Model System Using Self-Assembled Monolayers J. Am. Chem. Soc. 1993 115 23 10714 10721
16. S. C. Gill P. H. von Hippel Calculation of protein extinction coefficients from amino acid sequence data Anal. Biochem. 1989 182 2 319 326
17. G. M. Walker D. J. Beebe A passive pumping method for microfluidic devices Lab Chip 2002 2 3 131 134
18. B. H. Jo et al., Three-dimensional micro-channel fabrication in polydimethylsiloxane (PDMS) elastomer J. Microelectromech. Syst. 2000 9 1 76 81
19. C. Thibault et al., Poly(dimethylsiloxane) Contamination in Microcontact Printing and Its Influence on Patterning Oligonucleotides Langmuir 2007 23 21 10706 10714
20. M. W. A. Skoda et al., Optimizing the PMIRRAS signal from a multilayer system and application to self-assembled monolayers in contact with liquids J. Electron Spectrosc. Relat. Phenom. 2009 172 1Äì3 21 26
21. T. A. Fong et al., SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types Cancer Res. 1999 59 1 99 106
22. T. Buffeteau et al., Anisotropic Optical Constants of Alpha-Helix and Beta-Sheet Secondary Structures in the Infrared J. Phys. Chem. B 2000 104 18 4537 4544
23. B. L. Frey R. M. Corn Covalent attachment and derivatization of poly(l-lysine) monolayers on gold surfaces as characterized by polarization-modulation FT-IR spectroscopy Anal. Chem. 1996 68 18 3187 3193
24. B. Millauer et al., Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant Nature 1994 367 6463 576 9
25. S. Lee et al., Autocrine VEGF signaling is required for vascular homeostasis Cell 2007 130 4 691 703
26. H. Helotera K. Alitalo The VEGF family, the inside story Cell 2007 130 4 591 2
27. G. H. Mahabeleshwar et al., Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis Circ. Res. 2007 101 6 570 80
28. R. Soldi et al., Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2 EMBO J. 1999 18 4 882 92
29. T. V. Byzova et al., A mechanism for modulation of cellular responses to VEGF: activation of the integrins Mol. Cell. 2000 6 4 851 60
30. P. R. Somanath A. Ciocea T. V. Byzova Integrin and growth factor receptor alliance in angiogenesis Cell Biochem. Biophys. 2009 53 2 53 64
31. X. Xin et al., Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo Am. J. Pathol. 2001 158 3 1111 20
32. C. J. Shen et al., Decreased cell adhesion promotes angiogenesis in a Pyk2-dependent manner Exp. Cell Res. 317 13 1860 71
33. M. A. Lafleur et al., Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs) J. Cell. Sci. 2002 115 Pt 17 3427 38
34. R. L. Saunders D. A. Hammer Assembly of Human Umbilical Vein Endothelial Cells on Compliant Hydrogels Cell. Mol. Bioeng. 3 1 60 67
35. O. F. Zouani et al., Differentiation of pre-osteoblast cells on poly(ethylene terephthalate) grafted with RGD and/or BMPs mimetic peptides Biomaterials 2010 31 32 8245 53
36. H. Briscoe et al., A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice J. Leukoc. Biol. 2000 68 4 538 44
37. W. J. Dower Targeting growth factor and cytokine receptors with recombinant peptide libraries Curr. Opin. Chem. Biol. 1998 2 3 328 34
38. A. Shrivastava A. D. Nunn M. F. Tweedle Designer peptides: learning from nature Curr. Pharm. Des. 2009 15 6 675 81
39. R. Binetruy-Tournaire et al., Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis EMBO J. 2000 19 7 1525 33
40. U. Engstrom et al., Identification of a peptide antagonist for platelet-derived growth factor J. Biol. Chem. 1992 267 23 16581 7
41. Z. Li et al., Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics FASEB J. 2005 19 14 1978 85
42. F. Maruta et al., Identification of FGF receptor-binding peptides for cancer gene therapy Cancer Gene Ther. 2002 9 6 543 52
43. I. N. Michon et al., The effect of TGF-beta receptor binding peptides on smooth muscle cells Biochem. Biophys. Res. Commun. 2002 293 4 1279 86
44. X. Qin et al., Identification of a novel peptide ligand of human vascular endothelia growth factor receptor 3 for targeted tumour diagnosis and therapy J. Biochem. 2007 142 1 79 85